The expression of both DBC1 and SIRT1 predicted shorter survival of gastric carcinoma [15], breast carcinoma [14], clear cell renal cell carcinoma [12], soft-tissue sarcoma [13], and diffuse large B cell lymphoma [13,16]. This evidence concerns the gene CCAR2 and clear cell renal carcinoma.